Icon Group, Australia’s largest dedicated provider of cancer care, with a growing reach into New Zealand and Asia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order includes a significant suite of Varian cancer treatment hardware and software, including the first Asia-Pacific purchase of Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI) driven holistic solution designed to increase the capability, flexibility, and efficiency of radiotherapy.
This significant order also includes the Varian TrueBeam® linear accelerator and Halcyon™ radiotherapy system, as well as the Identify™ Guidance System that aids in the efficient delivery of pinpoint precise radiation treatment. This technology not only delivers precise radiation therapy but can also reduce patient’s emotional stress by eliminating the need for tattoo markings, as well as minimising treatment times.